Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Binhong Wen"'
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 29, Iss 6, p 237 (2024)
Background: Under fasting conditions, the pathway converting gluconeogenesis precursors into muscle glycogen becomes crucial due to reduced glycogen reserves. However, there is limited research on skeletal muscle gluconeogenesis and the impact of fas
Externí odkaz:
https://doaj.org/article/45e05b8ef6834b4b84d4eb94bc1a5aaa
Dkks have inhibitory effects on Wnt signaling pathway, which is involved in the development of skin and its appendages and the regulation of hair growth. The nucleotide sequences were compared and analyzed to further investigate the relationship betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::653a3e0de0869533acb596bd38190f48
https://doi.org/10.21203/rs.3.rs-2677896/v1
https://doi.org/10.21203/rs.3.rs-2677896/v1
Autor:
Binhong Wen, Hailong Wan, Yufang Li, Tao Ning, Nan Cui, Junfen Wang, Xia Zhang, Linong Ji, Wei Feng, Yunliang Zhang, Binhong Duan, Xueying Wang
Publikováno v:
Diabetes Therapy
Introduction BEYOND 7 demonstrated that a higher starting dose (0.3 U/kg) of insulin glargine 100 U/mL (Gla-100) is as safe as the standard starting dose (0.2 U/kg) in Chinese individuals with type 2 diabetes who had uncontrolled hyperglycaemia despi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9302f81c49fdad379a34111b16699bda
http://europepmc.org/articles/PMC8385002
http://europepmc.org/articles/PMC8385002
Autor:
Yaochuan Mi, Yanyang Zhang, Wei He, Xiaochen Wang, Lu Zhao, Xiaona Hu, Binhong Wen, Shuo Yang
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 1126-1137 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 1126-1137 (2021)
Diabetic osteoporosis (DOP) is a chronic complication of diabetes in the skeletal system. High level of miR-340-5p may be harmful to the bone formation. In this study, the DOP model of rats was successfully established via streptozotocin (STZ) and ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598e9d0b82473844b46590f67995e894
https://pubmed.ncbi.nlm.nih.gov/33818278
https://pubmed.ncbi.nlm.nih.gov/33818278
Autor:
Linong Ji, Hailong Wan, Binhong Wen, Xueying Wang, Junfen Wang, Rongwen Bian, Wuyan Pang, Jian Tian, Yan Wang, Fang Bian, Zhengnan Gao, Alex Condoleon, Wei Feng, Xia Zhang, Nan Cui
Publikováno v:
Diabetes, Obesity and Metabolism. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e3f2d1a1975ffa6bee1ea28900457f8
https://doi.org/10.1111/dom.14053
https://doi.org/10.1111/dom.14053
Autor:
null Linong Ji, null Hailong Wan, null Binhong Wen, null Xueying Wang, null Junfen Wang, null Rongwen Bian, null Wuyan Pang, null Jian Tian, null Yan Wang, null Fang Bian, null Zhengnan Gao, null Alex Condoleon, null Wei Feng, null Xia Zhang, null Nan Cui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e5d1d14e077873f39a1004307e6326
https://doi.org/10.1111/dom.13967/v2/response1
https://doi.org/10.1111/dom.13967/v2/response1
Autor:
Jian Tian, Linong Ji, Junfen Wang, Binhong Wen, Zhengnan Gao, Alex Condoleon, Hailong Wan, Yan Wang, Fang Bian, Xueying Wang, Xia Zhang, Wei Feng, Rongwen Bian, Wuyan Pang, Nan Cui
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To determine the safety of a higher starting dose of basal insulin in overweight/obese patients with type 2 diabetes (T2D). Materials and methods This 16‐week, randomized, multicentre, open‐label trial enrolled adults with T2D (body mass inde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3257822f780454de3b4b681f295f58
https://pubmed.ncbi.nlm.nih.gov/31944546
https://pubmed.ncbi.nlm.nih.gov/31944546
Autor:
Xueying Wang, Xia Zhang, Binhong Wen, Wei Feng, Linong Ji, Junfen Wang, Nan Cui, Wuyan Pang, Rongwen Bian, Hailong Wan
Publikováno v:
Diabetes. 68
With type 2 diabetes (T2D) progression, patients require insulin, but insufficient titration often leads to poor glycemic control. A higher insulin starting dose may reduce the optimal dose deficit, but whether this procedure increases hypoglycemia r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3150d888d9e952091a64dbd6ca61b3c
https://doi.org/10.2337/db19-1102-p
https://doi.org/10.2337/db19-1102-p
Autor:
Linong Ji, Hailong Wan, Binhong Wen, Xueying Wang, Junfen Wang, Rongwen Bian, Wuyan Pang, Jian Tian, Yan Wang, Fang Bian, Zhengnan Gao, Alex Condoleon, Wei Feng, Xia Zhang, Nan Cui
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4012b79522e19f44098837c04bb48f34
https://doi.org/10.2139/ssrn.3437797
https://doi.org/10.2139/ssrn.3437797
Liraglutide, a glucagon-like peptide-1 receptor agonist, is an anti-diabetic medicine associated with a reduced risk of fracture in diabetic patients. In the present study, rats with streptozotocin (STZ)-induced diabetes and/or bilateral ovariectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e43ac222decd792c4b75354f5e2b7dc
https://europepmc.org/articles/PMC5958780/
https://europepmc.org/articles/PMC5958780/